Data Curation and Entry in DIDB – October Summary

In October, we added 149 citations in DIDB, including 50 in vitro (with 14 articles published in Oct 2021) and 99 in vivo articles (with 35 articles published in Oct 2021).

Five recently approved NDAs/BLAs were also added with the 4 following NDAs: belumosodil (REZUROCK), belzutifan (WELIREG), fexinidazole (FEXINIDAZOLE TABLETS), and odevixibat (BYLVAY), and 1 BLA: anifrolumab (SAPHNELO)

You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.

As always, feel free to contact us if you have any questions or comments.